Melatonin helps maintain mitochondria in mouse brains
Experiments in melatonin-deficient mice found reduced mitochondrial production and quality, while supplementation restored production-related signals and the abundance of proteins involved in energy production.

Our read
Mechanisms- Studied:
- Experiments in melatonin-deficient mice, against melatonin-deficient mice without supplementation
- What changed:
- Melatonin supplementation increased mitochondrial DNA and restored energy-production proteins compared with melatonin deficiency alone
- The catch:
- Molecular signals, mitochondrial DNA, and protein abundance served as stand-ins for mitochondrial production
- In the record:
- One of 69 papers on mitochondrial transplantation on record: 6 with results in people, 13 in animals.
Editor of record: Boris Djordjevic · AgingResearch.News
Mice were studied in animal experiments on how the body’s own melatonin affects mitochondria, the energy-producing structures inside cells. Brain comparisons at 8 weeks, 20 weeks and 1 year of age linked aging to reduced signals for making mitochondria, fewer copies of mitochondrial DNA and lower levels of energy-production proteins.
Genetically modified mice deficient in melatonin showed age-dependent reductions in signals supporting mitochondrial production. They also had less mitochondrial DNA, lower mitochondrial protein levels and more oxidative damage to mitochondria. Melatonin supplementation restored production-related signals, increased mitochondrial DNA and restored energy-production protein abundance. The authors concluded that the body’s own melatonin was required to maintain mitochondrial production and quality in the brain.
Why it matters
Mitochondrial failure contributes to neuronal aging and neurodegeneration. The authors suggest that declining melatonin contributes to damage to nerve-cell extensions and the loss of neurons.
Caveats
Supplementation experiments in mice leave open whether melatonin supplements would preserve brain cells during human aging.
Melatonin is part of Rhonda Patrick's supplement routineMore supplements
The paper
University of Pittsburgh; Helexva Inc.
The Journal of Clinical Investigation, Nov 19, 2026, Open access, CC BY



Comments
Be the first to comment.